about
Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse.A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastomaMMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line.Nerve growth factor as an angiogenic factor.Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium.The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib.Aquaporin-4 contributes to the resolution of peritumoural brain oedema in human glioblastoma multiforme after combined chemotherapy and radiotherapy.Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle.Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse.Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer.Altered blood-brain barrier development in dystrophic MDX mice.Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: a morphological and molecular study.Eotaxin/CCL11 in idiopathic retroperitoneal fibrosisFirst evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidantNeridronate inhibits angiogenesis in vitro and in vivoIn vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycinTryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomasMast cells contribute to vasculogenic mimicry in multiple myelomaAngiogenic response induced by acellular aortic matrix in vivoHIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouseAngiogenesis and mast cells in human breast cancer sentinel lymph nodes with and without micrometastasesMicrovascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanomaAn alternative in vivo system for testing angiogenic potential of human neuroblastoma cellsMicrocirculation density and maturity in uterine and soft tissue leiomyosarcomas: an immunohistochemical studyPiperine: role in prevention and progression of cancer
P50
Q33241652-FFC62143-DAFE-4844-81E6-CBD2801B263AQ33292668-19FF450E-F24E-4D71-B141-C2D3E71E6D53Q33660218-2AE6A04E-8CF1-48A6-9977-C50C05D60E36Q35083651-E0E68E15-89DB-4F6E-82EF-340D724D4D06Q35839982-6DE3FB73-D828-4D50-B208-05C8C03F32DEQ36057462-0DE5B1A0-EE76-4C8B-BD5C-D99DE82930B2Q36926140-7939A0DC-E57F-4431-A8C7-35DED5544147Q37580210-0255753D-A279-40C2-B8A0-0ABD23D8EF6CQ38252537-48CFEAE7-B821-4BC8-8B93-904AF4E4776BQ40084316-DD4A10B8-6BDC-4F6E-8113-6CE23B376576Q45047567-646AAFDF-63DD-4E99-A504-278DB9FAAC66Q46434974-9F9F8334-5B05-4181-925A-D7FB60CA140EQ46456982-5E13BA6E-6CDA-471E-B9F4-3A1485EC8E33Q46833911-D13273FE-4964-4A3E-995B-CDAF021AC0D4Q47665860-47B4700F-97FB-4513-8838-284BC79D44E1Q51007790-CF220B7D-FE14-4FA7-8687-949558ED19BDQ54346166-B405A54E-8287-4ABB-B550-D288EF16F41BQ58885868-FB78DA51-4970-4D6C-B974-07A83B74E4D7Q59467052-028AA9E8-CD79-417C-96FE-623E2825B3B1Q79360669-63DC71D1-8AE3-4451-851A-61AC0344B362Q79427875-37B54D37-B929-416D-B7CE-3B0DDA514303Q80233451-7CFCD1B7-EE69-4A95-AD7B-8703A45B8930Q80515628-EA60CE42-A7DF-436D-BE18-2C16CD1E28E2Q80975944-627D6F2C-89B4-4177-A340-4A9F87D2149AQ81037363-7B61FA4B-3710-4D20-8C33-66A8A7C7BF02Q81459054-55D36D1A-7E1F-4978-B7DF-5073FB6D29F2Q81828276-B574B96B-1418-4EA1-8DC0-F6ED1297048DQ83198675-BF5358EE-EE74-4F67-95FF-125B3A4EC28DQ87420212-9DF3B899-BC7C-4452-8ADA-A6C2FFB65CE3Q91624985-CCDA1980-430A-46FA-986C-12B50C9F73C9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Domenica Mangieri
@ast
Domenica Mangieri
@en
Domenica Mangieri
@es
Domenica Mangieri
@nl
Domenica Mangieri
@sl
type
label
Domenica Mangieri
@ast
Domenica Mangieri
@en
Domenica Mangieri
@es
Domenica Mangieri
@nl
Domenica Mangieri
@sl
prefLabel
Domenica Mangieri
@ast
Domenica Mangieri
@en
Domenica Mangieri
@es
Domenica Mangieri
@nl
Domenica Mangieri
@sl
P106
P21
P31
P496
0000-0003-4871-1701